Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
5.5 CHF
78.37 M CHF
548.46 M CHF
3.63 M
About YPSOMED HLDG
Sector
Industry
CEO
Simon Michel
Website
Headquarters
Burgdorf
Founded
2003
ISIN
CH0019396990
FIGI
BBG000BTC8J2
Ypsomed Holding AG engages in the development and manufacture of injection systems for self-medication of drugs by patients, most notably used to treat diabetes. It operates through the following segments: Ypsomed Diabetes Care, Ypsomed Delivery Systems, and Others. The Ypsomed Diabetes Care segment is involved in the products that are sold directly to hospitals, doctors, pharmacies, and patients via Ypsomed subsidiaries and distributors. The Ypsomed Delivery Systems segment focuses on the pharmaceutical and biotech customers with injection systems and related services. The Others segment consists of Ypsotec and properties not used for operational purposes. The company was founded by Wilhelm Michel on December 29, 2003, and is headquartered in Burgdorf, Switzerland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of YPSN is 410.0 CHF — it has increased by 1.49% in the past 24 hours. Watch YPSOMED HLDG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange YPSOMED HLDG stocks are traded under the ticker YPSN.
YPSN stock has risen by 6.22% compared to the previous week, the month change is a −0.36% fall, over the last year YPSOMED HLDG has showed a 57.69% increase.
We've gathered analysts' opinions on YPSOMED HLDG future price: according to them, YPSN price has a max estimate of 495.00 CHF and a min estimate of 392.00 CHF. Watch YPSN chart and read a more detailed YPSOMED HLDG stock forecast: see what analysts think of YPSOMED HLDG and suggest that you do with its stocks.
YPSN reached its all-time high on Sep 26, 2024 with the price of 439.0 CHF, and its all-time low was 43.5 CHF and was reached on Jul 28, 2011. View more price dynamics on YPSN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
YPSN stock is 2.11% volatile and has beta coefficient of 0.02. Track YPSOMED HLDG stock price on the chart and check out the list of the most volatile stocks — is YPSOMED HLDG there?
Today YPSOMED HLDG has the market capitalization of 5.59 B, it has decreased by −5.15% over the last week.
Yes, you can track YPSOMED HLDG financials in yearly and quarterly reports right on TradingView.
YPSOMED HLDG is going to release the next earnings report on Nov 13, 2024. Keep track of upcoming events with our Earnings Calendar.
YPSOMED HLDG revenue for the last half-year amounts to 293.00 M CHF, despite the estimated figure of 295.60 M CHF. In the next half-year revenue is expected to reach 300.90 M CHF.
YPSN net income for the last half-year is 41.79 M CHF, while the previous report showed 36.58 M CHF of net income which accounts for 14.24% change. Track more YPSOMED HLDG financial stats to get the full picture.
YPSOMED HLDG dividend yield was 0.55% in 2023, and payout ratio reached 34.83%. The year before the numbers were 0.68% and 34.02% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 9, 2024, the company has 2.30 K employees. See our rating of the largest employees — is YPSOMED HLDG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. YPSOMED HLDG EBITDA is 155.93 M CHF, and current EBITDA margin is 28.43%. See more stats in YPSOMED HLDG financial statements.
Like other stocks, YPSN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade YPSOMED HLDG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So YPSOMED HLDG technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating YPSOMED HLDG stock shows the buy signal. See more of YPSOMED HLDG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.